Phase-contrast microscopy studies of early cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis

Experimental Lung Research

Volumn 34, Issue 2, 2008, Pages 49-67

  Janson, Veronica ^a   Behnam Motlagh, Parviz ^a   Henriksson, Roger ^a   Hörstedt, Per ^a   Engström, Karl Gunnar ^a   Grankvist, Kjell ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Cisplatin; Malignant pleural mesothelioma (MPM); Phase contrast microscopy (PCM); Scanning electron microscopy (SEM)

Indexed keywords

CASPASE 3; CASPASE 7; CISPLATIN; DNA FRAGMENT; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CELL SIZE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; INCUBATION TIME; MALIGNANT MESOTHELIOMA; NICK END LABELING; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STATISTICAL ANALYSIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CELL SEPARATION; CELL SHAPE; CELL SIZE; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; INHIBITORY CONCENTRATION 50; MESOTHELIOMA; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, PHASE-CONTRAST; PLEURAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 39049137125     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140701884398     Document Type: Article

References (47)

1. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny MV, Malorni W, Knight RA, Piacentini M, Nagata S, Melino G: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 2005;12(Suppl 2):1463-1467.
2. Berglund A, Glimelius B, Bergh J, Brodin O, Fjallskog ML, Hagberg H, von Heideman A, Larsson R, Tholander B, de la Torre M, Astrom G, Oberg K, Paro G, Nygren P: Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trial. Med Oncol. 2002;19:151-159.
3. Kurbacher CM, Cree IA: Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements. Methods Mol Med. 2005;110:101-120.
4. Kurbacher CM, Grecu OM, Stier U, Gilster TJ, Janat MM, Untch M, Konecny G, Bruckner HW, Cree IA: ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials. Recent Results Cancer Res. 2003;161:221-230.
5. Metzger R, Deglmann CJ, Hoerrlein S, Zapf S, Hilfrich J: Towards in-vitro prediction of an in-vivo cytostatic response of human tumor cells with a fast chemosensitivity assay. Toxicology. 2001;166:97-108.
6. Nakada S, Aoki D, Ohie S, Horiuchi M, Suzuki N, Kanasugi M, Susumu N, Udagawa Y, Nozawa S: Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response. Int J Gynecol Cancer. 2005;15: 445-452.
7. Sargent JM: The use of the MTT assay to study drug resistance in fresh tumour samples. Recent Results Cancer Res. 2003;161:13-25.
8. Villman K, Blomqvist C, Larsson R, Nygren P: Predictive value of in vitro assessment of cytotoxic drug activity in advanced breast cancer. Anticancer Drugs. 2005;16:609-615.
9. Engstrom KG, Grankvist K, Henriksson R: Early morphological detection of estramustine cytotoxicity measured as alteration in cell size and shape by a new technique of microperifusion. Eur J Cancer. 1991;27:1288-1295.
10. Behnam-Motlagh P, Grankvist K, Henriksson R, Engstrom KG: Response in shape and size of individual p31 cancer cells to cisplatin and ouabain: a computerized image analysis of cell halo characteristics during continuous perfusion. Cytometry. 2000;40:198-208.
11. Steele JP, Klabatsa A: Chemotherapy options and new advances in malignant pleural mesothelioma. Ann Oncol. 2005;16:345-351.
12. Fuertes MA, Alonso C, Perez JM: Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev. 2003;103:645-662.
13. Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A: Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health A. 2003;66:469-479.
14. Beretta GL, Righetti SC, Lombardi L, Zunino F, Perego P: Electron microscopy analysis of early localization of cisplatin in ovarian carcinoma cells. Ultrastruct Pathol. 2002;26:331-334.
15. Liang XJ, Shen DW, Chen KG, Wincovitch SM, Garfield SH, Gottesman MM: Trafficking and localization of platinum complexes in cisplatin-resistant cell lines monitored by fluorescence-labeled platinum. J Cell Physiol. 2005;202:635-641.
16. Molenaar C, Teuben JM, Heetebrij RJ, Tanke HJ, Reedijk J: New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy. J Biol Inorg Chem. 2000;5:655-665.
17. Safaei R, Katano K, Larson BJ, Samimi G, Holzer AK, Naerdemann W, Tomioka M, Goodman M, Howell SB: Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells. Clin Cancer Res. 2005;11:756-767.
18. Andersson B, Behnam-Motlagh P, Henriksson R, Grankvist K: Pharmacologicalmodulation of lung cancer cells for potassium ion depletion. Anticancer Res. 2005;25:2609-2616.
19. Andersson B, Janson V, Behnam-Motlagh P, Henriksson R, Grankvist K: Induction of apoptosis by intracellular potassium ion depletion: using the fluorescent dye PBFI in a 96-well plate method in cultured lung cancer cells. Toxicol In Vitro. 2006;20: 986-994.
20. Marklund L, Andersson B, Behnam-Motlagh P, Sandstrom PE, Henriksson R, Grankvist K: Cellular potassium ion deprivation enhances apoptosis induced by cisplatin. Basic Clin Pharmacol Toxicol. 2004;94:245-251.
21. Marklund L, Behnam-Motlagh P, Henriksson R, Grankvist K: Bumetanide annihilation of amphotericin B-induced apoptosis and cytotoxicity is due to its effect on cellular K+ flux. J Antimicrob Chemother. 2001;48:781-786.
22. --cotransport blocker bumetanide. Life Sci. 2000;66:PL319-P324.
23. Marklund L, Henriksson R, Grankvist K: Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide. Int J Cancer. 2001;93:577-583.
24. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
25. Barros LF, Kanaseki T, Sabirov R, Morishima S, Castro J, Bittner CX, Maeno E, Ando-Akatsuka Y, Okada Y: Apoptotic and necrotic blebs in epithelial cells display similar neck diameters but different kinase dependency. Cell Death Differ. 2003;10:687-697.
26. Hagmann J, Burger MM, Dagan D: Regulation of plasma membrane blebbing by the cytoskeleton. J Cell Biochem. 1999;73:488-499.
27. Collins JA, Schandi CA, Young KK, Vesely J, Willingham MC: Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem. 1997;45:923-934.
28. Deschesnes RG, Huot J, Valerie K, Landry J: Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol Biol Cell. 2001;12:1569-1582.
29. Huot J, Houle F, Rousseau S, Deschesnes RG, Shah GM, Landry J: SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol. 1998;143:1361-1373.
30. Mills JC, Stone NL, Erhardt J, Pittman RN: Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J Cell Biol. 1998;140:627-636.
31. van Gorp RM, Heeneman S, Broers JL, Bronnenberg NM, van Dam-Mieras MC, Heemskerk JW: Glutathione oxidation in calcium- and p38 MAPK-dependent membrane blebbing of endothelial cells. Biochim Biophys Acta. 2002;1591:129-138.
32. Lane JD, Allan VJ, Woodman PG: Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J Cell Sci. 2005;118:4059-4071.
33. Behnam-Motlagh P, Jonsson O, Engstrom KG, Henriksson R, Grankvist K: Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion. Br J Cancer. 1997;76:318-324.
34. Kravtsov VD, Daniel TO, Koury MJ: Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis. Am J Pathol. 1999;155:1327-1339.
35. Behnam-Motlagh P, Sandstrom PE, Henriksson R, Grankvist K: Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport. Pharmacol Toxicol. 2001;88:244-249.
36. Engstrom KG, Moller B, Meiselman HJ: Optical evaluation of red blood cell geometry using micropipette aspiration. Blood Cells. 1992;18:241-257; discussion 258-265.
37. Marklund SL, Westman NG, Lundgren E, Roos G: Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res. 1982;42:1955-1961.
38. Larsson R, Nygren P: A rapid fluorometric method for semiautomated determination of cytotoxicity and cellular proliferation of human tumor cell lines in microculture. Anticancer Res. 1989;9:1111-1119.
39. Behnam-Motlagh P, Engstrom KG, Henriksson R, Grankvist K: Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells. Eur J Cancer. 1999;35:145-153.
40. Kumar S: Caspase function in programmed cell death. Cell Death Differ. 2007;14:32-43.
41. Lakhani SA, Masud A, Kuida K, Porter GA, Jr., Booth CJ, Mehal WZ, Inayat I, Flavell RA: Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science. 2006;311:847-851.
42. Berndtsson M, Hagg M, Panaretakis T, Havelka AM, Shoshan MC, Linder S: Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int J Cancer. 2007;120:175-180.
43. Boudreault F, Grygorczyk R: Evaluation of rapid volume changes of substrate-adherent cells by conventional microscopy 3D imaging. J Microsc. 2004;215:302-312.
44. King MV: Dimensional changes in cells and tissues during specimen preparation for the electron microscope. Cell Biophys. 1991;18:31-55.
45. Ting-Beall HP, Zhelev DV, Hochmuth RM: Comparison of different drying procedures for scanning electron microscopy using human leukocytes. Microsc Res Tech. 1995;32:357-361.
46. Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, Laurent G, Gambert P, Solary E, Dimanche-Boitrel MT: Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res. 2004;64:3593-3598.
47. Alexopoulos LG, Erickson GR, Guilak F: A method for quantifying cell size from differential interference contrast images: validation and application to osmotically stressed chondrocytes. JMicrosc. 2002;205:125-135.